Article Type
Changed
Wed, 07/07/2021 - 10:38

Key clinical point: HCC patients with a higher expression of microRNA-889 had lower overall survival rates compared to those with low expression of miR-889.

Major finding: Overexpression of miR-889 significantly increased HCC cell proliferation, migration, and invasion in HCC cell lines, and overall survival was lower in the high expression of miR-889 (P = 0.013).

Study details: The data come from analysis of 113 fresh specimens of HCC and para-cancerous benign tissue from 113 patients with HCC who underwent partial or total hepatectomy between January 2010 and June 2015 at a single center.

Disclosures: The study received no outside funding. The researchers had no financial conflicts to disclose.  

Source: Wang H et al. Diagn Pathol. 2021 Jun 11. doi: 10.1186/s13000-021-01111-5.

Publications
Topics
Sections

Key clinical point: HCC patients with a higher expression of microRNA-889 had lower overall survival rates compared to those with low expression of miR-889.

Major finding: Overexpression of miR-889 significantly increased HCC cell proliferation, migration, and invasion in HCC cell lines, and overall survival was lower in the high expression of miR-889 (P = 0.013).

Study details: The data come from analysis of 113 fresh specimens of HCC and para-cancerous benign tissue from 113 patients with HCC who underwent partial or total hepatectomy between January 2010 and June 2015 at a single center.

Disclosures: The study received no outside funding. The researchers had no financial conflicts to disclose.  

Source: Wang H et al. Diagn Pathol. 2021 Jun 11. doi: 10.1186/s13000-021-01111-5.

Key clinical point: HCC patients with a higher expression of microRNA-889 had lower overall survival rates compared to those with low expression of miR-889.

Major finding: Overexpression of miR-889 significantly increased HCC cell proliferation, migration, and invasion in HCC cell lines, and overall survival was lower in the high expression of miR-889 (P = 0.013).

Study details: The data come from analysis of 113 fresh specimens of HCC and para-cancerous benign tissue from 113 patients with HCC who underwent partial or total hepatectomy between January 2010 and June 2015 at a single center.

Disclosures: The study received no outside funding. The researchers had no financial conflicts to disclose.  

Source: Wang H et al. Diagn Pathol. 2021 Jun 11. doi: 10.1186/s13000-021-01111-5.

Publications
Publications
Topics
Article Type
Sections
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Article Series
Clinical Edge Journal Scan: HCC July 2021
Gate On Date
Mon, 06/07/2021 - 10:30
Un-Gate On Date
Mon, 06/07/2021 - 10:30
Use ProPublica
CFC Schedule Remove Status
Mon, 06/07/2021 - 10:30
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Display survey writer
Reuters content
Disable Inline Native ads
WebMD Article